Bedrijfstakpensioenfonds Voor DE Media PNO continued to hold its position in Anthem, Inc. (NYSE:ANTM) during the third quarter, Holdings Channel reports. The institutional investor owned 7,700 shares of the company’s stock at the end of the third quarter. Bedrijfstakpensioenfonds Voor DE Media PNO’s holdings in Anthem were worth $965,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of ANTM. Emerald Acquisition Ltd. acquired a new position in shares of Anthem during the second quarter valued at about $242,981,000. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in Anthem by 18.0% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 8,575,511 shares of the company’s stock valued at $1,126,308,000 after buying an additional 1,306,670 shares during the last quarter. FMR LLC boosted its stake in Anthem by 9.3% in the second quarter. FMR LLC now owns 9,033,602 shares of the company’s stock valued at $1,186,473,000 after buying an additional 770,894 shares during the last quarter. Cohen & Steers Inc. boosted its stake in Anthem by 82,228.9% in the second quarter. Cohen & Steers Inc. now owns 740,960 shares of the company’s stock valued at $20,651,000 after buying an additional 740,060 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its stake in Anthem by 22.4% in the second quarter. Alliancebernstein L.P. now owns 3,295,738 shares of the company’s stock valued at $432,862,000 after buying an additional 602,123 shares during the last quarter. Institutional investors own 87.14% of the company’s stock.

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Anthem, Inc. (NYSE:ANTM) traded up 0.23% during mid-day trading on Friday, hitting $148.53. The stock had a trading volume of 1,405,200 shares. The company’s 50 day moving average is $144.93 and its 200-day moving average is $132.18. The stock has a market capitalization of $39.13 billion, a P/E ratio of 17.44 and a beta of 0.64. Anthem, Inc. has a 52 week low of $114.85 and a 52 week high of $149.58.

Anthem (NYSE:ANTM) last issued its quarterly earnings results on Wednesday, November 2nd. The company reported $2.45 EPS for the quarter, missing the Zacks’ consensus estimate of $2.47 by $0.02. The business had revenue of $21.13 billion for the quarter, compared to the consensus estimate of $20.77 billion. Anthem had a return on equity of 11.64% and a net margin of 2.74%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $2.73 earnings per share. On average, analysts expect that Anthem, Inc. will post $10.84 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 21st. Investors of record on Monday, December 5th were issued a dividend of $0.65 per share. The ex-dividend date was Thursday, December 1st. This represents a $2.60 dividend on an annualized basis and a yield of 1.75%. Anthem’s dividend payout ratio (DPR) is currently 30.52%.

TRADEMARK VIOLATION WARNING: “Anthem, Inc. (ANTM) Stake Maintained by Bedrijfstakpensioenfonds Voor DE Media PNO” was reported by Watch List News and is the propert of of Watch List News. If you are viewing this report on another domain, it was copied illegally and republished in violation of international trademark and copyright laws. The original version of this report can be viewed at http://www.watchlistnews.com/anthem-inc-antm-stake-maintained-by-bedrijfstakpensioenfonds-voor-de-media-pno/1060752.html.

Several research firms have commented on ANTM. Stifel Nicolaus cut Anthem from a “buy” rating to a “hold” rating and boosted their target price for the company from $143.24 to $155.00 in a research note on Wednesday, January 4th. They noted that the move was a valuation call. Wells Fargo & Company upgraded Anthem from a “market perform” rating to an “outperform” rating in a research note on Tuesday, November 15th. Cantor Fitzgerald set a $125.00 target price on Anthem and gave the company a “hold” rating in a research note on Wednesday, November 2nd. Evercore ISI began coverage on Anthem in a research note on Thursday, September 22nd. They issued a “hold” rating and a $133.00 target price on the stock. Finally, Zacks Investment Research upgraded Anthem from a “sell” rating to a “hold” rating in a research note on Monday, November 7th. Ten research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Anthem currently has an average rating of “Buy” and a consensus price target of $156.34.

In other Anthem news, EVP Jose D. Tomas sold 6,500 shares of the business’s stock in a transaction on Monday, January 9th. The stock was sold at an average price of $142.92, for a total value of $928,980.00. Following the sale, the executive vice president now directly owns 23,913 shares in the company, valued at $3,417,645.96. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Joseph Swedish sold 8,176 shares of the business’s stock in a transaction on Monday, December 12th. The shares were sold at an average price of $144.10, for a total value of $1,178,161.60. Following the completion of the sale, the insider now owns 75,601 shares in the company, valued at $10,894,104.10. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company’s stock.

About Anthem

Anthem, Inc is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Company has three segments: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business segments offer managed care products, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products.

5 Day Chart for NYSE:ANTM

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).

Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.